<button id="eiezk"><video id="eiezk"></video></button>

產(chǎn)品名稱

PD 0332991 hydrochloride - Palbociclib hydrochloride

產(chǎn)品貨號

Axon 1505 CAS [571189-11-2] MF C24H29N7O2.2HClMW 520.45 Purity: 99% Soluble in water Description An orally active cyclin-dependent kinase (CDK) inhibitor, specifically targeting on CDK4 and CDK6; a potential agent for the treatment of breast cancer; water soluble hydrochloride salt form, ideal for in vivo experiments. Another salt form, PD 0332991 isethionate (Axon 2052) is also available. Prime Source Information

產(chǎn)品價格

現(xiàn)貨詢價，電話：010-67529703

產(chǎn)品規(guī)格

產(chǎn)品品牌

axonmedchem

產(chǎn)品概述

產(chǎn)品詳情

PD 0332991 hydrochloride - Palbociclib hydrochloride

Based on 16 reference(s) in Google Scholar 9 10 16

Axon 1505

CAS [571189-11-2]

MF C24H29N7O2.2HCl
MW 520.45

Purity: 99%
Soluble in water

PD 0332991 hydrochloride

Description

An orally active cyclin-dependent kinase (CDK) inhibitor, specifically targeting on CDK4 and CDK6; a potential agent for the treatment of breast cancer; water soluble hydrochloride salt form, ideal for in vivo experiments. Another salt form, PD 0332991 isethionate (Axon 2052) is also available.

Prime Source Information:
The molecule of PD0332991 contains multiple basic nitrogens, which could form 1 to 4 eq HCl salt of PD0332991 and its accurate salt form has been determined by microanalysis and specified on certificate of analysis (COA) of every batch of our samples.

RL Sutherland and EA Musgrove. CDK inhibitors as potential breast cancer therapeutics: new evidence for enhanced efficacy in ER+ disease. Breast Cancer Res. 2009, 11(6), 112-113.

RS Finn et al. PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Res. 2009, 11(5), R77.?

D.W. Fry et al. Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. Mol. Cancer Ther. 2004, 3, 1427-1438.

Certificate of Analysis
Material Safety Data Sheet

Cell Cycle Regulation Cell Signaling & Oncology p53-Tumor Suppression EC 2.7.11.22 CDK Pfizer Licensed Products

CDK4 and CDK6 inhibitor

Chemical name

6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one hydrochloride

Source information

Pfizer compound; Sold for research purposes under agreement from Pfizer Inc.

Parent CAS No.

[571190-30-2]

產(chǎn)品資料

<button id="eiezk"><video id="eiezk"></video></button>